Yanni Ma
Impact in
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Pharmacology top 10%
- Berberine and alkaloids research
- Pharmacological Effects of Natural Compounds
- Biological and pharmacological studies of plants
Papers in
-
- Ubiquitin and proteasome pathways 3
-
- Insect Pest Control Strategies 3
- Phytochemistry and Biological Activities 3
- Co-authors
- Fang Miao (3 shared papers)Xin‐Juan Yang (3 shared papers)Le Zhou (3 shared papers)Yao Yao (1 shared paper)Yang Rui (1 shared paper)Ningzhi Xu (3 shared papers)Fangjun Cao (1 shared paper)Hongxia Zhu (3 shared papers)
- Journals
- Artificial Cells Nanomedicine and Biotechnology (4 papers)Molecules (3 papers)BioMed Research International (2 papers)Stem Cell Research & Therapy (2 papers)Chemical and Pharmaceutical Bulletin (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yanni Ma
49 papers receiving 800 citations
Peers
Comparison fields: 5 of 90
- Pharmaceutical Science 45
- Pharmacology 59
- Pharmacology 98
- Molecular Medicine 29
- Hematology 52
Countries citing papers authored by Yanni Ma
This map shows the geographic impact of Yanni Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanni Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanni Ma more than expected).
Fields of papers citing papers by Yanni Ma
This network shows the impact of papers produced by Yanni Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanni Ma. The network helps show where Yanni Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanni Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 79 | |
| 2 | 2019 | 54 | |
| 3 | 2019 | 49 | |
| 4 | 2021 | 43 | |
| 5 | 2024 | 42 | |
| 6 | 2016 | 39 | |
| 7 | 2015 | 38 | |
| 8 | 2021 | 38 | |
| 9 | 2015 | 33 | |
| 10 | 2012 | 33 | |
| 11 | 2017 | 28 | |
| 12 | 2019 | 27 | |
| 13 | 2018 | 27 | |
| 14 | 2024 | 27 | |
| 15 | 2016 | 24 | |
| 16 | 2019 | 22 | |
| 17 | 2012 | 18 | |
| 18 | 2012 | 18 | |
| 19 | 2015 | 16 | |
| 20 | 2022 | 14 |
About Yanni Ma
Yanni Ma is a scholar working on Molecular Biology, Plant Science, Pharmacology, Oncology and Pharmacology, having authored 52 papers that have together received 813 indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (4 papers), Ubiquitin and proteasome pathways (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Insect Pest Control Strategies (3 papers), interferon and immune responses (3 papers), Phytochemistry and Biological Activities (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Pharmaceutical Science (45 citations), Pharmacology (59 citations), Pharmacology (98 citations), Molecular Medicine (29 citations) and Hematology (52 citations). Yanni Ma has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Fang Miao, Xin‐Juan Yang, Le Zhou, Yao Yao, Yang Rui, Ningzhi Xu, Fangjun Cao, Hongxia Zhu, Shufang Liang and Jieping Chen. Their work appears in journals such as Artificial Cells Nanomedicine and Biotechnology, Molecules, BioMed Research International, Stem Cell Research & Therapy and Chemical and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.